TR201620309A2 - Metformi̇n hi̇droklori̇t ve pi̇ogli̇tazon hi̇droklori̇ti̇n farmasöti̇k bi̇leşi̇mleri̇ - Google Patents
Metformi̇n hi̇droklori̇t ve pi̇ogli̇tazon hi̇droklori̇ti̇n farmasöti̇k bi̇leşi̇mleri̇ Download PDFInfo
- Publication number
- TR201620309A2 TR201620309A2 TR2016/20309A TR201620309A TR201620309A2 TR 201620309 A2 TR201620309 A2 TR 201620309A2 TR 2016/20309 A TR2016/20309 A TR 2016/20309A TR 201620309 A TR201620309 A TR 201620309A TR 201620309 A2 TR201620309 A2 TR 201620309A2
- Authority
- TR
- Turkey
- Prior art keywords
- hydrochloride
- pharmaceutical compositions
- pioglitazone
- metformin
- metformin hydrochloride
- Prior art date
Links
- GHUUBYQTCDQWRA-UHFFFAOYSA-N Pioglitazone hydrochloride Chemical compound Cl.N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 GHUUBYQTCDQWRA-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004329 metformin hydrochloride Drugs 0.000 title abstract 2
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical group Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 title abstract 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229960002827 pioglitazone hydrochloride Drugs 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Bu buluş, metformin hidroklorür ve pioglitazon hidroklorür içeren farmasötik bileşimler ile ilgilidir.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2016/20309A TR201620309A2 (tr) | 2016-12-30 | 2016-12-30 | Metformi̇n hi̇droklori̇t ve pi̇ogli̇tazon hi̇droklori̇ti̇n farmasöti̇k bi̇leşi̇mleri̇ |
| PCT/EP2017/084831 WO2018122385A1 (en) | 2016-12-30 | 2017-12-29 | Pharmaceutical compositions of metformin hydrochloride and pioglitazone hydrochloride |
| EP17211105.6A EP3342402A1 (en) | 2016-12-30 | 2017-12-29 | Pharmaceutical compositions of metformin hydrochloride and pioglitazone hydrochloride |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2016/20309A TR201620309A2 (tr) | 2016-12-30 | 2016-12-30 | Metformi̇n hi̇droklori̇t ve pi̇ogli̇tazon hi̇droklori̇ti̇n farmasöti̇k bi̇leşi̇mleri̇ |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201620309A2 true TR201620309A2 (tr) | 2018-07-23 |
Family
ID=60888288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2016/20309A TR201620309A2 (tr) | 2016-12-30 | 2016-12-30 | Metformi̇n hi̇droklori̇t ve pi̇ogli̇tazon hi̇droklori̇ti̇n farmasöti̇k bi̇leşi̇mleri̇ |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3342402A1 (tr) |
| TR (1) | TR201620309A2 (tr) |
| WO (1) | WO2018122385A1 (tr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115804770B (zh) * | 2022-11-16 | 2024-04-02 | 安徽杰玺医药有限公司 | 一种含有盐酸二甲双胍和盐酸吡格列酮的药物制剂及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3174901A (en) | 1963-01-31 | 1965-03-23 | Jan Marcel Didier Aron Samuel | Process for the oral treatment of diabetes |
| AR240698A1 (es) | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| DK0514452T4 (da) | 1990-02-09 | 2000-09-18 | Upjohn Co | Anvendelse af insulin-sensibiliserende midler til behandling af hypertension |
| BR9908911A (pt) | 1998-03-19 | 2001-10-02 | Bristol Myers Squibb Co | Sistema bifásico e processo de distribuição por liberação controlada de substâncias farmacêuticas de alta solubilidade |
| PE20091730A1 (es) * | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| TR200803177A2 (tr) * | 2008-05-06 | 2009-11-23 | Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. | Antihiperglisemik etkili metformîn - pioglitazon formülasyonu. |
| EP2441442A1 (en) * | 2010-10-08 | 2012-04-18 | LEK Pharmaceuticals d.d. | A pharmaceutical composition comprising a thiazolidinedione |
| WO2013074049A1 (en) * | 2011-11-03 | 2013-05-23 | Mahmut Bilgic | Micronized metformin |
| EP2638898A1 (en) * | 2012-03-16 | 2013-09-18 | Sanovel Ilac Sanayi ve Ticaret A.S. | Metformin and Pioglitazone Formulation with Different Release Profiles |
| EP2783681A1 (en) * | 2013-03-25 | 2014-10-01 | Sanovel Ilac Sanayi ve Ticaret A.S. | Extended release formulations of metformin |
-
2016
- 2016-12-30 TR TR2016/20309A patent/TR201620309A2/tr unknown
-
2017
- 2017-12-29 WO PCT/EP2017/084831 patent/WO2018122385A1/en active Application Filing
- 2017-12-29 EP EP17211105.6A patent/EP3342402A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018122385A1 (en) | 2018-07-05 |
| EP3342402A1 (en) | 2018-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20217239B (en) | Pharmaceutical composition | |
| EP3407976A4 (en) | COMPOSITIONS AND USES OF ALPHA-ADRENERGIC AGENTS | |
| MX2017004808A (es) | Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple. | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| PH12016501686A1 (en) | Pharmaceutical compositions of sitagliptin | |
| GEP20217240B (en) | Pharmaceutical composition | |
| IL273259A (en) | Production of pharmaceutical preparations | |
| PH12018500504A1 (en) | Compounds useful for inhibiting ror-gamma-t | |
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| PH12017502028A1 (en) | Vortioxetine pyroglutamate | |
| PL3468964T3 (pl) | Modulatory soce, ich kompozycje i zastosowania | |
| IL304109A (en) | Pharmaceutical preparations containing spinamide | |
| IN2014CH00840A (tr) | ||
| PH12017502148A1 (en) | Pharmaceutical compositions and use thereof | |
| TR201620309A2 (tr) | Metformi̇n hi̇droklori̇t ve pi̇ogli̇tazon hi̇droklori̇ti̇n farmasöti̇k bi̇leşi̇mleri̇ | |
| WO2016109361A3 (en) | 3-fluoro-benzonitrile inhibitors of 11-beta-hydroxylase | |
| MA40642A (fr) | Nouveaux dérivés peptidiques et leurs utilisations | |
| ZA202003079B (en) | Pharmaceutical compositions comprising safinamide | |
| LT3558261T (lt) | Farmacinės kompozicijos, apimančios safinamidą | |
| GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| IN2014MU00666A (tr) | ||
| IN2014CH00035A (tr) |